Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Genomic analysis identifies frequent deletions of Dystrophin in olfactory neuroblastoma.

Gallia GL, Zhang M, Ning Y, Haffner MC, Batista D, Binder ZA, Bishop JA, Hann CL, Hruban RH, Ishii M, Klein AP, Reh DD, Rooper LM, Salmasi V, Tamargo RJ, Wang Q, Williamson T, Zhao T, Zou Y, Meeker AK, Agrawal N, Vogelstein B, Kinzler KW, Papadopoulos N, Bettegowda C.

Nat Commun. 2018 Dec 21;9(1):5410. doi: 10.1038/s41467-018-07578-z.

2.

Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.

Weiss GJ, Liang WS, Izatt T, Arora S, Cherni I, Raju RN, Hostetter G, Kurdoglu A, Christoforides A, Sinari S, Baker AS, Metpally R, Tembe WD, Phillips L, Von Hoff DD, Craig DW, Carpten JD.

PLoS One. 2012;7(5):e37029. doi: 10.1371/journal.pone.0037029. Epub 2012 May 23.

3.

Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable FGFR3 Amplifications.

Lazo de la Vega L, McHugh JB, Cani AK, Kunder K, Walocko FM, Liu CJ, Hovelson DH, Robinson D, Chinnaiyan AM, Tomlins SA, Harms PW.

Mol Cancer Res. 2017 Nov;15(11):1551-1557. doi: 10.1158/1541-7786.MCR-17-0135. Epub 2017 Aug 3.

4.

Concurrent exome-targeted next-generation sequencing and single nucleotide polymorphism array to identify the causative genetic aberrations of isolated Mayer-Rokitansky-Küster-Hauser syndrome.

Chen MJ, Wei SY, Yang WS, Wu TT, Li HY, Ho HN, Yang YS, Chen PL.

Hum Reprod. 2015 Jul;30(7):1732-42. doi: 10.1093/humrep/dev095. Epub 2015 Apr 29.

PMID:
25924657
5.

Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature.

Czapiewski P, Kunc M, Gorczyński A, Haybaeck J, Okoń K, Reszec J, Lewczuk A, Dzierzanowski J, Karczewska J, Biernat W, Turri-Zanoni M, Castelnuovo P, Taverna C, Franchi A, La Rosa S, Sessa F, Klöppel G.

Hum Pathol. 2018 Sep;79:144-150. doi: 10.1016/j.humpath.2018.05.013. Epub 2018 May 25.

PMID:
29807052
6.

Estimation of copy number aberrations: Comparison of exome sequencing data with SNP microarrays identifies homozygous deletions of 19q13.2 and CIC in neuroblastoma.

Fransson S, Östensson M, Djos A, Javanmardi N, Kogner P, Martinsson T.

Int J Oncol. 2016 Mar;48(3):1103-16. doi: 10.3892/ijo.2016.3349. Epub 2016 Jan 19.

PMID:
26794043
7.

[Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].

Li X, Liu HG, Xie XJ, Han YD, Li M.

Zhonghua Bing Li Xue Za Zhi. 2008 Jul;37(7):458-64. Chinese.

PMID:
19035117
8.

Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract.

Wooff JC, Weinreb I, Perez-Ordonez B, Magee JF, Bullock MJ.

Am J Surg Pathol. 2011 Dec;35(12):1786-93. doi: 10.1097/PAS.0b013e3182363b78.

PMID:
22020045
9.

Ectopic primary olfactory neuroblastoma of the maxillary sinus.

Holmes M, Su SY, Bell D.

Ann Diagn Pathol. 2016 Jun;22:45-8. doi: 10.1016/j.anndiagpath.2016.04.001. Epub 2016 Apr 11. Review.

PMID:
27180059
10.

Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.

Czapiewski P, Kunc M, Haybaeck J.

Oncotarget. 2016 Aug 9;7(32):52584-52596. doi: 10.18632/oncotarget.9683. Review.

11.

Olfactory Neuroblastoma with Divergent Differentiation: An Unusual Histologic Finding in a Rare Tumor.

Meyer C, Hamersley ERS, Manosalva RE, Torske K, McIntyre N, Mitchell A.

Head Neck Pathol. 2017 Dec;11(4):531-536. doi: 10.1007/s12105-017-0781-6. Epub 2017 Feb 6.

12.

DNA methylation-based reclassification of olfactory neuroblastoma.

Capper D, Engel NW, Stichel D, Lechner M, Glöss S, Schmid S, Koelsche C, Schrimpf D, Niesen J, Wefers AK, Jones DTW, Sill M, Weigert O, Ligon KL, Olar A, Koch A, Forster M, Moran S, Tirado OM, Sáinz-Jaspeado M, Mora J, Esteller M, Alonso J, Del Muro XG, Paulus W, Felsberg J, Reifenberger G, Glatzel M, Frank S, Monoranu CM, Lund VJ, von Deimling A, Pfister S, Buslei R, Ribbat-Idel J, Perner S, Gudziol V, Meinhardt M, Schüller U.

Acta Neuropathol. 2018 Aug;136(2):255-271. doi: 10.1007/s00401-018-1854-7. Epub 2018 May 5. Erratum in: Acta Neuropathol. 2018 Sep;136(3):505.

PMID:
29730775
13.

Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping.

Anthony K, Arechavala-Gomeza V, Ricotti V, Torelli S, Feng L, Janghra N, Tasca G, Guglieri M, Barresi R, Armaroli A, Ferlini A, Bushby K, Straub V, Ricci E, Sewry C, Morgan J, Muntoni F.

JAMA Neurol. 2014 Jan;71(1):32-40. doi: 10.1001/jamaneurol.2013.4908.

PMID:
24217213
14.

Southern blot and PCR analyses of dystrophin gene deletions in Japanese patients with Duchenne muscular dystrophy.

Nakajima T, Matsuo M, Nakamura H, Fujiwara Y.

Kobe J Med Sci. 1991 Feb;37(1):21-33.

PMID:
1921260
15.

p63 Expression in olfactory neuroblastoma and other small cell tumors of the sinonasal tract.

Bourne TD, Bellizzi AM, Stelow EB, Loy AH, Levine PA, Wick MR, Mills SE.

Am J Clin Pathol. 2008 Aug;130(2):213-8. doi: 10.1309/TEDD2FCWH8W0H4HA.

PMID:
18628089
16.

Molecular diagnosis of Duchenne/Becker muscular dystrophy: enhanced detection of dystrophin gene rearrangements by oligonucleotide array-comparative genomic hybridization.

del Gaudio D, Yang Y, Boggs BA, Schmitt ES, Lee JA, Sahoo T, Pham HT, Wiszniewska J, Chinault AC, Beaudet AL, Eng CM.

Hum Mutat. 2008 Sep;29(9):1100-7. doi: 10.1002/humu.20841.

PMID:
18752307
17.

Odorant receptor genes are expressed in olfactory neuroblastoma.

Gonzalez-Kristeller DC, Gutiyama LM, Campos AH, Soares FA, Brentani H, Malnic B.

Genet Mol Res. 2013 Sep 10;12(3):3479-87. doi: 10.4238/2013.September.10.4.

18.

Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.

Topcagic J, Feldman R, Ghazalpour A, Swensen J, Gatalica Z, Vranic S.

PLoS One. 2018 Jan 11;13(1):e0191244. doi: 10.1371/journal.pone.0191244. eCollection 2018.

19.

Cytopathologic features of olfactory neuroblastoma.

Mahooti S, Wakely PE Jr.

Cancer. 2006 Apr 25;108(2):86-92.

20.

[Detection of rare mutations in the dystrophin gene].

Zimowski JG, Holding M, Fidziańska E, Fidziańska A, Ryniewicz B, Dobosz I, Hausmanowa-Petrusewicz I, Kostera-Pruszczyk A, Zdzienicka E, Kubalska J, Andrzejczyk A, Zaremba J.

Med Wieku Rozwoj. 2009 Apr-Jun;13(2):140-5. Polish.

PMID:
19837995

Supplemental Content

Support Center